Related Experiment Videos
Lung cancer: therapeutic options for stage IV and recurrent NSCLC
1University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Cancer Treatment and Research
|February 28, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN).
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC).
Cancer treatment reviews·2011
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026